Document is current
Any future updates will be listed below
-
Authors
Moiseenko, F. V.
Krasavina, M. A.
Agranov, I. R.
Artemieva, E. V.
Oganesian, A. P.
Gabina, A. S.
Makarkina, M. L.
Elsakova, E. O.
Henshtein, V. A.
Volkov, N. M.
Egorenkov, V. V.
Moiseenko, V. M.
Fedyanin, M. Yu.
Kopeina, G. S.
Zhivotovsky, B.
Zamaraev, A. V.
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 9 June 2025
Accepted: 30 June 2025
First Online: 3 July 2025
Declarations
:
: This retrospective study included 270 patients with NSCLC from a database of N.P. Napalkov St. Petersburg Clinical Research and Practical Center of Specialized Types of Medical Care (Oncological). The study protocol was approved by the Ethics Committee of this Center (Approval No. 4 from 14.03.2023). Informed consent was waived due to the retrospective nature of the study design.
: The authors declare no competing interests.
: Not applicable.
